Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer

International Journal of Cancer

Volumn 79, Issue 3, 1998, Pages 256-262

  Yamamichi, Keigo ^a   Uehara, Yoshihiko ^a   Kitamura, Naomi ^b   Nakane, Yasushi ^a   Hioki, Koshiro ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR GROWTH;

ADULT; AGED; ANTIGENS, CD44; BLOTTING, SOUTHERN; CELL ADHESION; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS; TIME FACTORS;

EID: 0031745390     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980619)79:3<256::AID-IJC8>3.0.CO;2-O     Document Type: Article

References (22)

1. CANNISTRA, S.A., KANSAS, G.S., NILOFF, J., DEFRANZO, B., KIM, Y. and OTTENSMEIER, C., Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res., 53, 3830-3838 (1993).
2. COX, D.R., Regression models and life-tables. J. Roy. Statist. Soc., 34B, 187-220 (1972).
3. DÄMMRICH, J., VOLLMERS, H.P., HEIDER, K.H. and MÜLLUR-HERMELINK, H.K., Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading. J. mol. Med., 73, 395-401 (1995).
4. FOLEY, K.P., LEONARD, M.W. and ENGEL, J.D., Quantitation of RNA using the polymerase chain reaction. Trends Genet., 9, 380-385 (1993).
5. GÜNTHERT, U., HOFMANN, M., RUDY, W., REBER, S., ZÖLLER, M., HAUSSMANN, I., MATZKU, S., WENZEL, A., PONTA, H. and HERRLICH, P., A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cell. Cell, 65, 13-24 (1991).
6. HAYNES, B.F., LIAO, H.X. and PATTON, K.L., The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms., Cancer Cells, 3, 347-350 (1991).
7. HOFMANN, M., RUDY, W., ZÖLLER, M., TÖLG, C., PONTA, H., HERRLICH, P. and GÜNTHERT, U., CD44 splice variants confer metastatic behavior in rat: homologous sequences are expressed in human tumor cell lines. Cancer Res., 51, 5292-5297 (1991).
8. HONG, R.L., LEE, W.J., SHUN, C.T., CHU, J.S. and CHEN, Y.C., Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinoma. Oncology, 52, 334-339 (1995).
9. JAPANESE RESEARCH SOCIETY FOR GASTRIC CANCER. The general rules for the gastric cancer study. Kanehara, Tokyo (1993).
10. JOENSUU, H., KLEMI, P.J., TOIKKANEN, S. and JALKANEN, S., Glycoprotein CD44 expression and its association with survival in breast cancer. Amer. J. Pathol., 143, 867-874 (1993).
11. KORETZ, K., MÖLLER, P., LEHNERT, T., HINZ, U., OTTO, H.F. and HERFARTH, C., Effect of CD44v6 on survival in colorectal carcinoma. Lancet, 345, 327-328 (1995).
12. MACKAY, C.R., TERPE, H.J., STAUDER, R., MARSTONE, W.L., STARK, H. and GÜNTHERT, U., Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol., 124, 71-82 (1994).
13. MATSUMURA, Y. and TARIN, D., Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058 (1992).
14. MAYER, B., JAUCH, K.W., GÜNTHERT, U., FIGDOR, C.G., SCHILDBERG, F.W., FUNKE, I. and JOHNSON, L.P., De-novo expression of CD44 and survival in gastric cancer. Lancet, 342, 1019-1022 (1993).
15. MIWA, T., WATANABE, A., YAMADA, Y., SHINO, Y., YAMADA, T., YAMASITA, J., MATSUDA, M. and NAKANO, H., Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript. Cancer, 77, 25-29 (1996).
16. MULDER, J.W.R., KRUYT, P.M., SEWNATH, M., OOSTIG, J., SELDENRIJK, C.A., WEIDEMA, W.F., OFFERHAUS, G.J.A. and PALS, S.T., Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344, 1470-1472 (1994).
17. NAKAJIMA-IIJIMA, S., HAMADA, H., REDDY, P. and KAKUNAGA, T., Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc. nat. Acad. Sci. (Wash.), 82, 6133-6137 (1985).
18. NISHIMURA, S., CHUNG, Y.S., YASHIRO, M., INOUE, T. and SOWA, M., CD44H plays an important role in peritoneal dissemination of scirrhous gastric cancer cells. Jpn. J. Cancer Res., 87, 1235-1244 (1996).
19. SCREATON, G.R., BELL, M.V., JACKSON, D.G., CORNELIS, F.B., GERTH, U. and BELL, J.I., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sci. (Wash.), 89, 12160-12164 (1992).
20. TÖLG, C., HOFFMANN, M., HERRLICH, P. and PONTA, H., Splicing choice from ten variant exons establishes CD44 variability. Nucl. Acids Res., 21, 1225-1229 (1993).
21. WIELENGA, V.J.M., HEIDER, K.H., OFFERHAUS, G.J.A., ADOLF, G.R., BERG, F.M., PONTA, H., HERRLICH, P. and PALS, S.T., Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53, 4754-4756 (1993).
22. YAMAMICHI, K., NAKANE, Y., OKAMURA, S., OSAWA, T., TANAKA, K. and HIOKI, K., Potential prediction of metastasis and recurrence using molecular biological examination of biopsy specimens in patients with gastric cancer. In: J.R. Siewert, and J.D. Roder (eds.), Progress in gastric cancer research 1997. Proceedings of the 2nd International Gastric Cancer Congress, Munich. pp. 409-413, International Proceedings Division, Bologna, Italy (1997).